Alloy Steel

Alloy Therapeutics is a biotechnology ecosystem company that democratizes access to foundational drug discovery platforms and services. The company's core technology, the ATX-Gx™ platform, is a suite of transgenic mice designed for the rapid discovery of human therapeutic antibodies. Alloy operates under a unique business model, providing non-exclusive access to its technologies to over 150 partners across academia, biotech, and large pharma. In addition to antibody discovery, Alloy offers platforms for TCR discovery (Fortress) and genetic medicines, as well as end-to-end discovery services. The company also functions as a venture studio, helping to launch and support new therapeutic companies within its ecosystem.